Novo Nordisk A/S (NONOF)
49.33
+1.05
(+2.17%)
USD |
OTCM |
Dec 11, 14:58
Novo Nordisk EPS Diluted (Quarterly): 0.7044 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Genmab A/S | 0.6431 |
| Ascendis Pharma A/S | -1.173 |
| Evaxion AS | -0.2862 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.132B |
| Revenue (Quarterly) | 11.74B |
| Total Expenses (Quarterly) | 8.607B |
| Enterprise Value | 225.33B |
| Gross Profit Margin (Quarterly) | 76.12% |
| Profit Margin (Quarterly) | 26.68% |
| Earnings Yield | 6.96% |
| Operating Earnings Yield | 9.01% |
| Normalized Earnings Yield | 6.959 |